Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer.
暂无分享，去创建一个
J. Tabernero | J. Jassem | J. Canon | Y. Humblet | G. Bodoky | P. Ruff | M. Błasińska-Morawiec | D. Cunningham | J. Douillard | J. Cassidy | F. Rivera | S. Siena | R. Burkes | K. Oliner | M. Barugel | I. Kocáková | M. Šmakal | M. Rother | R. Sidhu | Y. Tian | F. Xu